TOMI Regains Nasdaq Compliance After Bid Price and Equity Recovery
Event summary
- TOMI regained compliance with Nasdaq’s minimum bid price and stockholders’ equity requirements as of November 12, 2026.
- The company’s stock will continue trading on the Nasdaq Capital Market under the symbol TOMZ.
- CEO Dr. Halden Shane cited strengthened capital structure, improved operating performance, and disciplined cost management as key factors.
- TOMI plans to focus on converting backlog, expanding recurring revenue through its SteraMist platform, and advancing into food safety, life sciences, and defense sectors.
The big picture
TOMI’s regulatory compliance recovery reflects broader trends in small-cap companies navigating Nasdaq’s financial thresholds. The company’s focus on operational efficiency and sector expansion aligns with growing demand for advanced disinfection solutions in healthcare, defense, and food safety. The success of its SteraMist platform will be critical in sustaining long-term growth.
What we're watching
- Execution Risk
- Whether TOMI can sustain its operational improvements and convert its backlog into revenue.
- Market Expansion
- The pace at which TOMI advances into the food safety, life sciences, and defense sectors.
- Recurring Revenue
- How effectively TOMI expands recurring revenue through its SteraMist platform.
